M. Sarfraz Nawaz’s Post

Today is World Lymphoma Awareness Day. Lymphoma is a blood cancer that affects over 735,000 people worldwide each year. It can have a significant impact on the emotional and psychological well-being of patients. The theme for this year's campaign is "We Can't Wait to Focus on Our Feelings," which highlights the importance of addressing the emotional and psychological challenges of lymphoma. If you are a lymphoma patient or caregiver, know that you are not alone. There are many resources available to help you cope with the emotional and psychological challenges of lymphoma. You can find support groups, counseling, and other resources online or by contacting your local cancer center. #WorldLymphomaAwarenessDay #VectorPharma #WeCantWaitToFocusOnOurFeelings #oncology #lymphoma

All cancer patients deserve personalized biomarker-directed treatment options! Please view Labcorp Oncology's amazing Medical Directors, Drs. Previs and Strickland, discussing treatment options for patients with recurrent cervical cancer and how biomarker-directed therapies are transforming the standard of care during this molecular tumor board. #MolecularTumorBoard #PrecisionOncology #CervicalCancer

In this episode of #OncLiveOnAir, Dr Goy discusses the impact of CAR T-cell therapy on the lymphoma and multiple myeloma treatment paradigms and his anticipations for the future of hematologic oncology. #mmsm #oncology https://lnkd.in/eywTGN7N

See this month’s highlights from the ESMO - European Society for Medical Oncology portfolio - Oncology Advance Elsevier Oncology Annals of Research in Oncology #Cancer #CancerTreatment #ESMO #Leukemia #LungCancer #Lymphoma #Myeloma #OncoDaily #Oncology #OncologyAdvance

CAR-T Cell Therapy brings a new ray of hope in the fight against cancer. It has shown unprecedented response rates in patients with B-cell leukemia and lymphoma who were no longer responding to chemotherapy. In older patients with comorbidities and patients whose Bone Marrow Transplant relapsed, CAR-T Cell Therapy can be beneficial. Dr. Esha Kaul, Director - Haematology, Hemato – Oncology & BMT, Max Institute of Cancer Care, Vaishali, Delhi, India, sheds light on the transformative benefits of this therapy in this video. Watch to know more. #CARTcellTherapy #CancerTreatment #Oncology #MaxHealthcare

On #WorldBloodCancerDay, we’re taking a moment to recognize the need for transformational treatments for people across the globe who are diagnosed with lymphoma, leukemia or myeloma each day. At ADC Therapeutics, we’re working with urgency to develop #antibodydrugconjugates in areas of high unmet need to bring hope to patients with #cancer, including hematologic cancers. #WBCD

1st comprehensive report of relapse patterns in a large cohort of patients with primary CNS lymphoma Memorial Sloan Kettering Cancer Center Society for Neuro-Oncology #BrainTumor #CNS #Lymphoma #MSKRadiationOncology #OncoDaily #Oncology #SocietyOfNeuroOncology

Ryan Jacobs, the Director of Lymphoma at Levine Cancer Institute - Cleveland, presents in this MEDtalk an update on his research from the EHA 2023 meeting on AZD-0486, a novel CD19/CD3 T-cell engager used in treating relapsed refractory follicular lymphoma. The update includes patient responses and tolerability information, highlighting findings such as high overall response rates, complete remission rates, and low toxicity with the double step-up dosing method. 🔗Follow along as we cover EHA 2024: https://lnkd.in/dPW-ansy  #EHA24 #Lymphoma

Have a paper related to advances in transcriptomics especially in cancer metabolism? Thank you Dr Sun from 上海交通大学 for the invitation to co-edit this special issue in Oncology Research (Scopus's Highest Percentile : 84% in Oncology). The details of the call are available at https://lnkd.in/eErrwzEE. #Tumor #metabolism; #cancer #progression; #transcriptome analysis; #Cancer #Therapy (Deadline : 30/9/2024)